These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1330 related articles for article (PubMed ID: 11857487)

  • 1. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies.
    Bingle L; Brown NJ; Lewis CE
    J Pathol; 2002 Mar; 196(3):254-65. PubMed ID: 11857487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of macrophages in tumour progression.
    Siveen KS; Kuttan G
    Immunol Lett; 2009 Apr; 123(2):97-102. PubMed ID: 19428556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Repolarisation of Tumour-Associated Macrophages.
    van Dalen FJ; van Stevendaal MHME; Fennemann FL; Verdoes M; Ilina O
    Molecules; 2018 Dec; 24(1):. PubMed ID: 30577495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumour strategies aiming to target tumour-associated macrophages.
    Tang X; Mo C; Wang Y; Wei D; Xiao H
    Immunology; 2013 Feb; 138(2):93-104. PubMed ID: 23113570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response.
    Ong SM; Tan YC; Beretta O; Jiang D; Yeap WH; Tai JJ; Wong WC; Yang H; Schwarz H; Lim KH; Koh PK; Ling KL; Wong SC
    Eur J Immunol; 2012 Jan; 42(1):89-100. PubMed ID: 22009685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages: modulators of breast cancer progression.
    Lin EY; Pollard JW
    Novartis Found Symp; 2004; 256():158-68; discussion 168-72, 259-69. PubMed ID: 15027489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-associated macrophages as treatment targets in oncology.
    Mantovani A; Marchesi F; Malesci A; Laghi L; Allavena P
    Nat Rev Clin Oncol; 2017 Jul; 14(7):399-416. PubMed ID: 28117416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.
    Xu L; Xie X; Luo Y
    Eur J Cell Biol; 2021 Mar; 100(2):151153. PubMed ID: 33476912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Associated Macrophages as Target for Antitumor Therapy.
    Sawa-Wejksza K; Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):97-111. PubMed ID: 28660349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
    Scott EM; Jacobus EJ; Lyons B; Frost S; Freedman JD; Dyer A; Khalique H; Taverner WK; Carr A; Champion BR; Fisher KD; Seymour LW; Duffy MR
    J Immunother Cancer; 2019 Nov; 7(1):320. PubMed ID: 31753017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-dependent tumour development: a role for tumour associate macrophages?
    Marchesi M; Andersson E; Villabona L; Seliger B; Lundqvist A; Kiessling R; Masucci GV
    J Transl Med; 2013 Oct; 11():247. PubMed ID: 24093459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.
    Luheshi N; Davies G; Poon E; Wiggins K; McCourt M; Legg J
    Eur J Immunol; 2014 Jan; 44(1):162-72. PubMed ID: 24114634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct role of macrophages in different tumor microenvironments.
    Lewis CE; Pollard JW
    Cancer Res; 2006 Jan; 66(2):605-12. PubMed ID: 16423985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-Associated Macrophages (TAMs) in Colon Cancer and How to Reeducate Them.
    Yahaya MAF; Lila MAM; Ismail S; Zainol M; Afizan NARNM
    J Immunol Res; 2019; 2019():2368249. PubMed ID: 30931335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy.
    Guo Q; Jin Z; Yuan Y; Liu R; Xu T; Wei H; Xu X; He S; Chen S; Shi Z; Hou W; Hua B
    J Immunol Res; 2016; 2016():9720912. PubMed ID: 27975071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth.
    al-Sarireh B; Eremin O
    J R Coll Surg Edinb; 2000 Feb; 45(1):1-16. PubMed ID: 10815374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of microRNA activity amplifies IFN-γ-induced macrophage activation and promotes anti-tumour immunity.
    Baer C; Squadrito ML; Laoui D; Thompson D; Hansen SK; Kiialainen A; Hoves S; Ries CH; Ooi CH; De Palma M
    Nat Cell Biol; 2016 Jul; 18(7):790-802. PubMed ID: 27295554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophages: functional diversity, clinical significance, and open questions.
    Biswas SK; Allavena P; Mantovani A
    Semin Immunopathol; 2013 Sep; 35(5):585-600. PubMed ID: 23657835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage polarization in tumour progression.
    Sica A; Larghi P; Mancino A; Rubino L; Porta C; Totaro MG; Rimoldi M; Biswas SK; Allavena P; Mantovani A
    Semin Cancer Biol; 2008 Oct; 18(5):349-55. PubMed ID: 18467122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage regulation of tumor responses to anticancer therapies.
    De Palma M; Lewis CE
    Cancer Cell; 2013 Mar; 23(3):277-86. PubMed ID: 23518347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 67.